Literature DB >> 1583114

Evaluation of culture and the Gen-Probe PACE 2 assay for detection of Neisseria gonorrhoeae and Chlamydia trachomatis in endocervical specimens transported to a state health laboratory.

R J Limberger1, R Biega, A Evancoe, L McCarthy, L Slivienski, M Kirkwood.   

Abstract

The Gen-Probe PACE 2 assay (Gen-Probe Inc., San Diego, Calif.) was compared with culture for the detection of Neisseria gonorrhoeae in endocervical specimens that were mailed to the laboratory. During mail transport, the specimens were exposed to extremes of hot and cold weather for several days before arriving in the laboratory. Specimens on culture plates deteriorated during transport, as evidenced by many dead gonococcus-like colonies. The manufacturer's recommendation for reporting PACE 2 assay-positive results was modified to create a suspicious category for samples with relative light units near the positive cutoff value. Of a total of 4,869 specimens tested, 30 were positive by both methods and 102 were positive only by the PACE 2 assay. These additional 102 positive specimens were likely to be true positives, as indicated by several lines of indirect evidence, including detailed probe competition analysis, patient history, and the lack of false-positive results in hand-delivered specimens. Although Gen-Probe Inc. indicates that specimens are stable for up to 7 days, N. gonorrhoeae was easily detectable by the PACE 2 assay after 1 month of incubation at room temperature in the PACE 2 transport buffer. We also compared the Gen-Probe PACE 2 assay for Chlamydia trachomatis with culture on endocervical specimens delivered by same-day courier. Of 398 endocervical specimens tested, the PACE 2 assay detected 19 of 20 culture-positive samples. Although the assay failed to detect one culture-positive sample, it was able to detect two very weak culture-suspicious samples. Finally, PACE 2 assays for N. gonorrhoeae and C. trachomatis performed on the same samples indicated that the coinfection rate was 40% for women attending five family planning clinics. We concluded that the Gen-Probe PACE 2 assay system should be considered for use in testing those specimens that are transported to the laboratory through the mail.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1583114      PMCID: PMC265242          DOI: 10.1128/jcm.30.5.1162-1166.1992

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  11 in total

1.  Growth of Chlamydia trachomatis in McCoy cells treated with cytochalasin B.

Authors:  D Sompolinsky; S Richmond
Journal:  Appl Microbiol       Date:  1974-12

Review 2.  Epidemiology of sexually transmitted Chlamydia trachomatis infections.

Authors:  S E Thompson; A E Washington
Journal:  Epidemiol Rev       Date:  1983       Impact factor: 6.222

3.  Comparison of the Gen-Probe PACE 2 system, direct fluorescent-antibody, and cell culture for detecting Chlamydia trachomatis in cervical specimens.

Authors:  P C Iwen; T M Blair; G L Woods
Journal:  Am J Clin Pathol       Date:  1991-04       Impact factor: 2.493

4.  API QuadFERM+ with rapid DNase for identification of Neisseria spp. and Branhamella catarrhalis.

Authors:  W M Janda; K L Zigler; J J Bradna
Journal:  J Clin Microbiol       Date:  1987-02       Impact factor: 5.948

5.  Improved transport system for Neisseria gonorrhoeae in clinical specimens.

Authors:  D A Symington
Journal:  J Clin Microbiol       Date:  1975-12       Impact factor: 5.948

6.  Comparison of Gen-Probe DNA probe test and culture for the detection of Neisseria gonorrhoeae in endocervical specimens.

Authors:  E S Panke; L I Yang; P A Leist; P Magevney; R J Fry; R F Lee
Journal:  J Clin Microbiol       Date:  1991-05       Impact factor: 5.948

7.  Performance of a nonisotopic DNA probe for detection of Chlamydia trachomatis in urogenital specimens.

Authors:  J A Kluytmans; H G Niesters; J W Mouton; W G Quint; J A Ijpelaar; J H Van Rijsoort-Vos; L Habbema; E Stolz; M F Michel; J H Wagenvoort
Journal:  J Clin Microbiol       Date:  1991-12       Impact factor: 5.948

8.  Use of New York City medium for improved recovery of Neisseria gonorrhoeae from clinical specimens.

Authors:  P A Granato; C Schneible-Smith; L B Weiner
Journal:  J Clin Microbiol       Date:  1981-05       Impact factor: 5.948

9.  Cultivation of Chlamydia trachomatis in cycloheximide-treated mccoy cells.

Authors:  K T Ripa; P A Mårdh
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

10.  Fluorescent monoclonal antibody for confirmation of Neisseria gonorrhoeae cultures.

Authors:  B E Laughon; J M Ehret; T T Tanino; B Van der Pol; H H Handsfield; R B Jones; F N Judson; E W Hook
Journal:  J Clin Microbiol       Date:  1987-12       Impact factor: 5.948

View more
  19 in total

1.  Evaluation of an in-house polymerase chain reaction for detection of Neisseria gonorrhoeae in urogenital samples.

Authors:  R Roymans; G Onland; A Jansz; W Quint; E Boel
Journal:  J Clin Pathol       Date:  1999-06       Impact factor: 3.411

2.  The value of non-culture techniques for diagnosis of Chlamydia trachomatis infections: making the best of a bad job.

Authors:  D Taylor-Robinson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1992-06       Impact factor: 3.267

3.  Comparison of DNA probe (Gen-Probe) with culture for the detection of Neisseria gonorrhoeae in an urban STD programme.

Authors:  J R Schwebke; M E Zajackowski
Journal:  Genitourin Med       Date:  1996-04

4.  Detection of Chlamydia pneumoniae in clinical specimens by polymerase chain reaction using nested primers.

Authors:  C M Black; P I Fields; T O Messmer; B P Berdal
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1994-09       Impact factor: 3.267

5.  Use of gen-probe probe competition assay as a supplement to probes for direct detection of Chlamydia trachomatis and Neisseria gonorrhoeae in urogenital specimens.

Authors:  G L Woods; D M Garza
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

6.  Evaluation of Clearview and Magic Lite tests, polymerase chain reaction, and cell culture for detection of Chlamydia trachomatis in urogenital specimens.

Authors:  J A Kluytmans; W H Goessens; J W Mouton; J H van Rijsoort-Vos; H G Niesters; W G Quint; L Habbema; E Stolz; J H Wagenvoort
Journal:  J Clin Microbiol       Date:  1993-12       Impact factor: 5.948

7.  Comparison of the Syva MicroTrak enzyme immunoassay and Gen-Probe PACE 2 with cell culture for diagnosis of cervical Chlamydia trachomatis infection in a high-prevalence female population.

Authors:  L M Clarke; M F Sierra; B J Daidone; N Lopez; J M Covino; W M McCormack
Journal:  J Clin Microbiol       Date:  1993-04       Impact factor: 5.948

8.  Incidence of Neisseria gonorrhoeae isolates negative by Syva direct fluorescent-antibody test but positive by Gen-Probe accuprobe test in a sexually transmitted disease clinic population.

Authors:  J L Beebe; M P Rau; S Flageolle; B Calhoon; J S Knapp
Journal:  J Clin Microbiol       Date:  1993-09       Impact factor: 5.948

9.  Detection of Chlamydia trachomatis in urethral and urine samples from symptomatic and asymptomatic male patients by the polymerase chain reaction.

Authors:  A Stary; B Choueiri; I Hörting-Müller; P Halisch; L Teodorowicz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1996-06       Impact factor: 3.267

10.  Evaluation of nucleic acid-based test (PACE 2C) for simultaneous detection of Chlamydia trachomatis and Neisseria gonorrhoeae in endocervical specimens.

Authors:  P C Iwen; R A Walker; K L Warren; D M Kelly; S H Hinrichs; J Linder
Journal:  J Clin Microbiol       Date:  1995-10       Impact factor: 5.948

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.